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Introduction: Thyroglobulin (Tg) determination is used for follow-up and 
monitoring of patients with differentiated cancer of the thyroid. In these 
patients, Tg levels drop to undetectable (or very low) levels after total or near-
total thyroidectomy and successful treatment with radio-labelled iodine. If a 
rise in Tg levels is observed during the follow-up, it can indicate a recurrence 
of the cancer. Thus, analytical performance of the different available Tg
assays in the lower range of measurement is of importance. Unfortunately, 
this has been evaluated in very few studies. 
Material and methods: We used two Tg automated methods:
-Beckman-Coulter Access
-Roche Modular
These methods are claimed to be calibrated against the same material 
(CRM457). 
Roche claims a limit of detection (LOD) <0.1 ng/mL and a functional sensitivity 
(FS) <1 ng/mL. 
Beckman also claims a LOD of 0.1 ng/mL but is less clear on the FS, even if 
they claim a CV<10% for concentrations >1 ng/mL.
We thus defined the LOD (value significantly different from zero with a 
probability of 99.7%) and the FS (lowest value who gave a CV of 20% when low 
values samples were assayed in triplicates on 5 different days) of the two 
assays. 
Then we defined the beta-expectations tolerance limits for 5 samples free of 
anti-Tg antibodies ranging from about 0.2 to 2 ng/mL by running them on
triplicate during 5 different days. 
Finally, we focused on 36 patients presenting low Tg levels (with no anti-Tg
antibodies) to compare the results obtained with the two assays.
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In other words, a patient presenting a Tg value of 0.30 with the Access could 
either range fro 0.25 to 0.35 with less than 5% of probability to fall out of this 
range. Run on Modular, this patient would have a value that could range 
from 0.24 to 0.57 with a chance greater than 5% to fall out of this range.
Conclusion: 
The performance of the 2 instruments is acceptable in the lower range of Tg assays, but Access presents more robust results. 
There is also a calibration problem with the Roche assay, even if claimed to be calibrated against CRM457. The first of the two 
calibrators used to fit to the Master curve of the instrument is probably too high (around 4 ng/mL) whereas Access uses four calibrators, 
the first around 1 ng/mL. Results obtained with the 2 methods are not transposable.  
